Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
about
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseasesAdiponectin as a potential biomarker of vascular diseaseAMP-activated protein kinase: a target for drugs both ancient and modernAdenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapyEndocrine and Metabolic Effects of Adipose Tissue in Children and Adolescents55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in MicePPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney diseaseAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeAdipocytes as regulators of energy balance and glucose homeostasisEffects of interventions on adiponectin and adiponectin receptors.EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?Amelioration of insulin resistance in rat cells by Astragalus polysaccharides and associated mechanisms.Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors.AMPK activation: a therapeutic target for type 2 diabetes?Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial DysfunctionInverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes.PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.(-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells.Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chainMetabolic regulation by C1q/TNF-related protein-13 (CTRP13): activation OF AMP-activated protein kinase and suppression of fatty acid-induced JNK signalingTranscriptional regulation of an insulin-sensitizing adipokine adipolin/CTRP12 in adipocytes by Krüppel-like factor 15.CTRP1 protein enhances fatty acid oxidation via AMP-activated protein kinase (AMPK) activation and acetyl-CoA carboxylase (ACC) inhibition.Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytesThe orphan nuclear receptor small heterodimer partner is required for thiazolidinedione effects in leptin-deficient mice.Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention.Obesity-associated improvements in metabolic profile through expansion of adipose tissue.Adiponectin action: a combination of endocrine and autocrine/paracrine effects.An Evi1-C/EBPβ complex controls peroxisome proliferator-activated receptor γ2 gene expression to initiate white fat cell differentiation.Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.Mitoflash altered by metabolic stress in insulin-resistant skeletal muscle.Exploring metabolic dysfunction in chronic kidney disease.Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthmaRetinaldehyde represses adipogenesis and diet-induced obesity.Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanismAdiponectin receptors form homomers and heteromers exhibiting distinct ligand binding and intracellular signaling properties.
P2860
Q24612698-B751F029-DB71-4E95-B9AA-9907519B7FA3Q26821925-9CDE4ED5-3555-4C8E-823B-A8B8EC954205Q26864424-5BAC9EED-4A9B-4148-944E-3E184F3BD770Q28068120-C4AD08C6-1FD4-428F-AE57-ED2EADB8C01CQ28082438-6BE0C032-2332-4520-BCCB-1D9EEF56F733Q28547237-379328F5-F61C-4A2A-B97F-32F4CBBDD95BQ28742454-19D4F421-DE60-4152-BA84-AC94FA80BD61Q29619211-A805F4F3-6E82-441B-BE24-6956CFFBBCB7Q29619448-C2082D3A-242C-4AC7-9FD5-9B1FB52696D0Q33629849-D9060318-8E44-4101-950A-1AD1E02C9A41Q33660008-E110B8CA-40EA-4684-9458-E22D5A7B8592Q33706165-B893F483-78A9-4CE5-B820-C31E26040FCBQ33736175-98C003EB-3781-4853-9A3A-F60B1B1EB504Q33779662-49F37C4E-F9EB-4F6A-B794-D01B31B16480Q33790412-022E71A7-3A66-4B12-9AE3-9F2AF69ED154Q33824564-7A4EBBD0-2F91-4EC6-B4BF-60979DF977AFQ33839167-8FF25ACF-BC48-4586-A782-C8CB93636272Q34230412-1E76CF98-1589-4717-85C0-94580427CBB0Q34374048-324AEA1C-D7F1-46AB-A2FE-BB567FBFD6ACQ34412650-39C6BC09-49EF-4C52-8B1C-FE7745F7FE94Q34442391-6522E289-68DA-456B-B153-368856FF1BB8Q34590354-FF9E718D-6039-494A-9323-45EB79C63A05Q34893444-5EF1B9D9-DD50-4D71-A089-2C9DC3A84591Q34962935-871DD25B-D5E7-4480-9284-046062ADE99FQ35073031-5B84507B-7501-483A-81A2-306F186CB163Q35668856-F0A11BC3-27C1-492D-9154-1FC2B87C9875Q35683960-3AF3E278-670F-4550-B94A-263DCE70B418Q35810498-5AA5237E-4372-4DE2-A422-B5F7B47B28C8Q35856946-CACFC78A-71F7-4D92-9DCB-D574DBF9C505Q35945161-9097D9DB-C198-42FC-A40B-C34903A52D64Q35971216-B0A26B0A-528B-4FB9-A366-18A76552DA98Q36023330-F2955AD9-22CF-4125-8781-01C01D3D7588Q36078772-25631D94-2775-43B9-A7C9-037C36B8F518Q36097167-3CC05069-B33D-4983-B8DA-7FF296A5A115Q36109269-E2257459-7F97-40F6-B244-1DF3A6DDA360Q36123347-7A72BEC2-16AE-4736-AC21-7D210979D397Q36440045-58BCF3A9-BA6B-417C-A901-063455E07390Q36444754-562842D2-199A-4713-9AF3-DC2E5BDCB3A7Q36555556-02E8FE5A-ED3B-471F-8BCF-8863FB1FD885Q36579485-5ABAA84F-F250-415A-9625-75CFF22BA558
P2860
Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pioglitazone ameliorates insul ...... ent and -independent pathways.
@en
type
label
Pioglitazone ameliorates insul ...... ent and -independent pathways.
@en
prefLabel
Pioglitazone ameliorates insul ...... ent and -independent pathways.
@en
P2093
P356
P1476
Pioglitazone ameliorates insul ...... ent and -independent pathways.
@en
P2093
Hidemi Satoh
Hiroki Kumagai
Hitomi Ogata
Iseki Takamoto
Kaoru Sugi
Kazuyuki Tobe
Kumpei Tokuyama
Masao Moroi
Michiro Ishikawa
Naoto Kubota
P304
P356
10.1074/JBC.M505649200
P407
P50
P577
2006-01-23T00:00:00Z